Viewing Study NCT03148132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-30 @ 2:29 PM
Study NCT ID: NCT03148132
Status: COMPLETED
Last Update Posted: 2019-01-09
First Post: 2017-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
Sponsor: Universidad Autonoma de San Luis Potosí
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module